XML 39 R27.htm IDEA: XBRL DOCUMENT v3.25.2
Fair Value of Financial Instruments (Tables)
6 Months Ended
Jun. 30, 2025
Fair Value Disclosures [Abstract]  
Schedule of Financial Instruments Measured at Fair Value on a Recurring Basis
At June 30, 2025, the Company classified its financial instruments measured at fair value on a recurring basis in the following valuation hierarchy:
June 30, 2025Quoted Prices in Active Markets for Identical Assets (Level 1)Significant Other Observable Inputs (Level 2)Significant Unobservable Inputs (Level 3)Fair Value Based on NAV Practical ExpedientTotal Fair Value
Fixed maturities
U.S. treasury bonds$43,911 $— $— $— $43,911 
U.S. agency bonds – mortgage-backed— 22,467 — — 22,467 
Non-U.S. government bonds— 53,976 — — 53,976 
Collateralized loan obligations— 68,686 — — 68,686 
Corporate bonds— 16,761 — — 16,761 
Equity securities— — 11,191 — 11,191 
Other investments
— — 127,728 34,377 162,105 
Total investments$43,911 $161,890 $138,919 $34,377 $379,097 
As a percentage of total assets3.8%14.0%12.0%3.0%32.8%
Underwriting-related derivative liability$— $— $3,984 $— $3,984 
December 31, 2024Quoted Prices in Active Markets for Identical Assets (Level 1)Significant Other Observable Inputs (Level 2)Significant Unobservable Inputs (Level 3)Fair Value Based on NAV Practical ExpedientTotal Fair Value
Schedule of Significant Unobservable Inputs for Determining Fair Value of Other Investments
The following table provides a summary of quantitative information regarding the significant unobservable inputs used in determining the fair value of other investments measured at fair value on a recurring basis under the Level 3 classification at June 30, 2025:
 Fair ValueValuation TechniqueUnobservable InputsRange
Privately held equity investments - common shares$5,181 Quarterly financial statementsPrice/book ratios of comparable public companies   
Privately held equity investments - preferred shares10,741 Quarterly financial statementsPrivately calculated enterprise valuations
Other investments - Investments in direct lending entities49,978 Quarterly financial statementsPrivately calculated enterprise valuations
Equity method investments measured at fair value option73,019 Quarterly financial statementsPrivately calculated enterprise valuations
Total Level 3 investments$138,919  
Underwriting-related derivative liability$3,984 Discounted cash flowsDuration matched discount rates5.0%to6.0%
Schedule of Reconciliation of Other Investments Measured at Fair value on a Recurring Basis Using Level 3 Inputs
The following table shows the reconciliation of beginning and ending balances for investments measured at fair value on a recurring basis using Level 3 inputs for the three and six months ended June 30, 2025, respectively. The Company includes any related interest and dividend income in net investment income and are excluded from the reconciliation in the table below:
For the Three and Six Months Ended June 30,2025
Balance - beginning of period$— 
Acquired Level 3 investments137,188 
Purchases1,723 
Sales(163)
Net realized and unrealized gains during the period
171 
Total Level 3 investments - end of period$138,919 
Schedule of Carrying Value and Fair Value of Senior Notes The following table presents the respective principal amount and fair values for the Senior Notes as at June 30, 2025:
June 30, 2025
 
Principal AmountFair Value
Senior Notes - MHLA – 6.625%
$110,000 $65,516 
Senior Notes - MHNC – 7.75%
152,361 100,254 
Total Senior Notes$262,361 $165,770